Fibroid Uterus Clinical Trials

7 recruiting

Fibroid Uterus Trials at a Glance

8 actively recruiting trials for fibroid uterus are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Baltimore, Beachwood, and Créteil. Lead sponsors running fibroid uterus studies include Johns Hopkins University, Eman Elkattan, and Charles University, Czech Republic.

Browse fibroid uterus trials by phase

Treatments under study

About Fibroid Uterus Clinical Trials

Looking for clinical trials for Fibroid Uterus? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Fibroid Uterus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Fibroid Uterus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 4

Prescription of Letrozole for Uterine Myoma

FibroidLeiomyomaFibroid Uterus+1 more
University of California, San Francisco140 enrolled5 locationsNCT06143631
Recruiting
Phase 2

The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.

Fibroid Uterus
Johns Hopkins University100 enrolled2 locationsNCT06536517
Recruiting

Comparison of Operative Hysteroscopy Performed in the Operating Room Versus Outpatient Settings

Fibroid UterusPolyp UterusRetained Products of Conception
Centre Hospitalier Intercommunal Creteil400 enrolled1 locationNCT07146659
Recruiting
Phase 4

QL Block in Laparoscopic Myomectomy

Postoperative PainFibroid Uterus
Joseph Findley MD80 enrolled1 locationNCT05979493
Recruiting
Phase 2

Effects of Simvastatin on Uterine Leiomyoma Size

LeiomyomaFibroid UterusFibroid Tumor+2 more
Johns Hopkins University60 enrolled1 locationNCT03400826
Recruiting

Fertility Limiting Diseases of Pelvic Organs and Their Influence on Receptivity of Endometrial Cavity: Prospective Clinical Trial

EndometriosisAdenomyosisFibroid Uterus
Charles University, Czech Republic236 enrolled1 locationNCT06991595
Recruiting
Not Applicable

Temporary Artery Clipping for Robotically-assisted Myomectomy, a Multicentric Randomized Controlled Trial

Fibroid Uterus
Universitaire Ziekenhuizen KU Leuven82 enrolled4 locationsNCT06269809
Recruiting

Studying the effect of fibroids versus adenomyosis on the ovarian artery blood flow in comparison to normal subjects.

-women with adenomyosis detected by ultrasound and confirmed by histopathology-women with fibroid uterus detected by ultrasound and confirmed by histopathology
Eman Elkattan150 enrolled1 locationACTRN12614000139673